🔴 Lipocine is trading 7% down in pre-market with no clear company-specific catalyst identified

Lipocine is trading at $2.28 (-6.94%) after no clear company-specific announcement was identified for September 8, 2026.

• Broader sentiment is moderately weaker, with the Dow down 0.79% and S&P 500 down 0.36%.
• Recent company coverage concerns earlier clinical and financial updates, not a new September 8 catalyst.
• The decline may reflect risk-off trading, but causation remains unconfirmed.